NEON THERAPEUTICS, INC. Operating Cash Flow
NEON THERAPEUTICS, INC. reported Operating Cash Flow of -$14.28 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2020-05-01
- NEON THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2020-03-31 was -$14.28M.
- NEON THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-12-31 was -$15.46M.
- NEON THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-09-30 was -$16.71M.
- NEON THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-06-30 was -$20.08M.
- NEON THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2019 was -$73.41M.
- NEON THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2018 was -$63.43M.
- NEON THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2017 was -$41.28M.
- NEON THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2016 was -$24.16M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$14.28M 10-Q · filed 2020-05-01 | -$29.74M derived: sum of 2 quarters · filed 2020-05-01 | -$46.46M derived: sum of 3 quarters · filed 2020-05-01 | -$66.54M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-12-31 | -$15.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$32.18M derived: sum of 2 quarters · filed 2020-03-02 | -$52.26M derived: sum of 3 quarters · filed 2020-03-02 | -$73.41M 10-K · filed 2020-03-02 |
| 2019-09-30 | -$16.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$36.79M derived: sum of 2 quarters · filed 2019-11-12 | -$57.95M 10-Q · filed 2019-11-12 | -$75.83M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-06-30 | -$20.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$41.24M 10-Q · filed 2019-08-06 | -$59.12M derived: sum of 3 quarters · filed 2020-05-01 | -$75.11M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-03-31 | -$21.16M 10-Q · filed 2020-05-01 | -$39.04M derived: sum of 2 quarters · filed 2020-05-01 | -$55.03M derived: sum of 3 quarters · filed 2020-05-01 | -$69.65M derived: sum of 4 quarters · filed 2020-05-01 |
| 2018-12-31 | -$17.89M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$33.88M derived: sum of 2 quarters · filed 2020-03-02 | -$48.50M derived: sum of 3 quarters · filed 2020-03-02 | -$63.43M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$15.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$30.61M derived: sum of 2 quarters · filed 2019-11-12 | -$45.54M 10-Q · filed 2019-11-12 | -$57.46M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$14.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$29.55M 10-Q · filed 2019-08-06 | -$41.47M derived: sum of 3 quarters · filed 2019-08-06 | -$53.24M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$14.93M 10-Q · filed 2019-05-13 | -$26.84M derived: sum of 2 quarters · filed 2019-05-13 | -$38.62M derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | -$11.91M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | -$23.69M derived: sum of 2 quarters · filed 2019-03-11 | -$41.28M 10-K · filed 2019-03-11 | |
| 2017-09-30 | -$11.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$29.37M 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$17.59M 10-Q · filed 2018-08-06 | |||
| 2016-12-31 | -$24.16M 10-K · filed 2019-03-11 |